Jin, F., Xiao, D., Zhao, T., & Yu, M. (2020). Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression. Oncology Letters, 19(1), 858. https://doi.org/10.3892/ol.2019.11157
Chicago Style (17th ed.) CitationJin, Fanjie, Di Xiao, Tiansuo Zhao, and Ming Yu. "Proteasome Inhibitor MG132 Suppresses Pancreatic Ductal Adenocarcinoma-cell Migration by Increasing ESE3 Expression." Oncology Letters 19, no. 1 (2020): 858. https://doi.org/10.3892/ol.2019.11157.
MLA (9th ed.) CitationJin, Fanjie, et al. "Proteasome Inhibitor MG132 Suppresses Pancreatic Ductal Adenocarcinoma-cell Migration by Increasing ESE3 Expression." Oncology Letters, vol. 19, no. 1, 2020, p. 858, https://doi.org/10.3892/ol.2019.11157.